# Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis

Source: https://onco.cc/trials/nct07736495/  
OnCo record `nct07736495` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial in colorectal cancer, run by Ain Shams University, now recruiting.

## Summary

Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis is a phase 2/3, randomised interventional study registered as NCT07736495 by Ain Shams University, with a registry enrolment figure of 50 participants, started 2026-07-27 and due to reach its primary completion in 2026-12-27. Interventions recorded: alpha lipoic acid 600 mg twice daily; Placebo Tablet. Conditions listed: Colorectal Cancer. Primary outcome: Serum levels of malondialdehyde (MDA). Sites: Egypt. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT07736495
- Phase: 2/3
- Setting: Evaluation of the Protective Effect of Alpha-Lipoic Acid Against 5-Fluorouracil-Induced Oral Mucositis in Colorectal Cancer Patients
- Sponsor: Ain Shams University
- Enrolled: 50

## Sources

- ClinicalTrials.gov NCT07736495: https://clinicaltrials.gov/study/NCT07736495

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07736495.json